408. Safety and Immunogenicity of Meningococcal Serogroup B Vaccine (4CMenB) and 13-Valent Pneumococcal Vaccine (PCV13) Administered Concomitantly with Routine Infant Vaccines (RIVs) to Healthy United States (US) Infants: A Randomized Controlled Stud
408. Safety and Immunogenicity of Meningococcal Serogroup B Vaccine (4CMenB) and 13-Valent Pneumococcal Vaccine (PCV13) Administered Concomitantly with Routine Infant Vaccines (RIVs) to Healthy United States (US) Infants: A Randomized Controlled Stud
Pavitra Keshavan, Daniela Toneatto, Elisa Cinconze, Mauro Trapani et al.
Journal
Open Forum Infectious Diseases
Topics
Pneumonia and Respiratory Infections
article
408. Safety and Immunogenicity of Meningococcal Serogroup B Vaccine (4CMenB) and 13-Valent Pneumococcal Vaccine (PCV13) Administered Concomitantly with Routine Infant Vaccines (RIVs) to Healthy United States (US) Infants: A Randomized Controlled Stud
Pavitra Keshavan, Daniela Toneatto, Elisa Cinconze, Mauro Trapani, Maria Lattanzi, Danielle Morelle, Debasish Saha, J.-M. Martin, Laura Tomasi Cont, Walter J Rok
article en
Abstract
No abstract available for this paper.
Publication Tag
Open Forum Infectious DiseasesVol. 13(Supplement_1)
Institutions
University of Pittsburgh (US), GlaxoSmithKline (Belgium) (BE), Toscana Life Sciences (IT), New England Center for Clinical Research (US)